http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-202920640-U

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6530af83849b3a19a1268ef52d5de63
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-258
filingDate 2012-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a8c49ebe9da6e839883d0bf36e93a7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3ac3e68caf8116a817ee10b8d06110a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e228c126adcc338aa7d533ce9c2b63e
publicationDate 2013-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-202920640-U
titleOfInvention Panax notoginseng saponins injection production system
abstract The utility model provides a panax notoginseng saponins injection production system which comprises a batching system, a filtering system, a diluting system and an encapsulating system, wherein the batching system is connected with the filtering system, the filtering system is connected with the diluting system, and the diluting system is connected with the encapsulating system. Due to the technical scheme, the defects of unstable content of panax notoginseng saponins injection, low clarity and more adverse effects at present are overcome, and the panax notoginseng saponins injection production system is good in clinical effect and wide in application and has a vast market prospect.
priorityDate 2012-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297

Total number of triples: 17.